Alzamend Neuro
Quarterly Financials
| Values in thousands | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | -12 | -12 | |
EBITDA | -2,700 | -1,126 | -1,025 | -1,345 |
EBIT | -1,138 | -1,037 | -1,357 | |
Net Income | -2,702 | -1,139 | -1,039 | -1,362 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,362 | -898 | -1,423 | -3,310 |
Cash | 5,620 | 3,948 | 3,358 | 4,093 |
Basic Shares | 2,106 | 778 | 5,518 | 3,532 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -50 | -50 | -23 | |
EBITDA | -4,446 | -9,887 | -14,847 | -12,316 |
EBIT | -4,496 | -9,937 | -14,870 | -12,319 |
Net Income | -4,514 | -9,948 | -14,878 | -12,362 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -8,922 | 12,134 | ||
Free Cash Flow | -6,868 | -8,417 | -8,923 | -6,720 |
Cash | 3,948 | 376 | 5,140 | 14,063 |
Basic Shares | 450 | 3,383 | 3,251 | 2,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-07-31 | -$1.28 |
2025-04-30 | -$9.48 |
2025-01-31 | -$1.71 |
2024-10-31 | -$3.60 |
